Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Moodys
AstraZeneca
Express Scripts
Citi
Fuji
Merck
Mallinckrodt
Teva
Julphar

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,524,555

« Back to Dashboard

Summary for Patent: 6,524,555
Title: Metered dose inhaler for salmeterol
Abstract:A metered dose inhaler having part or all of its internal metallic surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising salmeterol, or a salt thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents and one or more excipients.
Inventor(s): Ashurst; Ian C. (Ware, GB), Britto; Ignatius Loy (Cary, NC), Herman; Craig Steven (Raleigh, NC), Li-Bovet; Li (Chapel Hill, NC), Riebe; Michael Thomas (Raleigh, NC)
Assignee: SmithKline Beecham Corp. (Philadelphia, PA)
Application Number:09/562,946
Patent Claim Types:
see list of patent claims
Composition; Formulation; Delivery; Device;

Drugs Protected by US Patent 6,524,555

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,524,555

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 9701113 ➤ Subscribe
African Regional IP Organization (ARIPO) 979 ➤ Subscribe
Austria 250439 ➤ Subscribe
Austria 297773 ➤ Subscribe
Australia 5481196 ➤ Subscribe
Australia 718263 ➤ Subscribe
Bulgaria 102022 ➤ Subscribe
Bulgaria 64117 ➤ Subscribe
Brazil 9604977 ➤ Subscribe
Canada 2217954 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Novartis
Boehringer Ingelheim
UBS
Argus Health
Cantor Fitzgerald
Baxter
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot